Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Not Confirmed
Not Confirmed
10-12 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Industry Trade Show
Not Confirmed
10-12 December, 2025
Digital content

15 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250915935641/en/Biocytogen-Announces-ADC-Innovator-Tubulis-Has-Signed-Global-Exclusive-License-Agreement-for-Single-Antibody

03 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250903434045/en/Biocytogen-Enters-into-Agreement-with-Merck-KGaA-Darmstadt-Germany-to-Advance-Antibody-Conjugated-Lipid-Based-Delivery-Solutions

28 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250728835434/en/Biocytogen-Upgrades-Preclinical-Service-Platform-and-Launches-Revamped-Global-Website

09 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250709188805/en/Biocytogen-Enters-into-Antibody-Licensing-Agreement-with-BeOne-Medicines-to-Accelerate-Innovative-Drug-Development

17 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250617098086/en/Biocytogen-Responds-to-Harbour-BioMeds-Patent-Claims-RenNano-is-an-Independently-Developed-Platform-with-Distinct-Innovation-and-Full-Legal-Standing

05 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250605093754/en/Biocytogen-Secures-Japan-Patent-for-RenMab-Platform-Expands-Global-Patent-Portfolio-for-RenMice-Fully-Human-AntibodyTCR-Platform
ABOUT THIS PAGE